Virological and biological characteristics of cervical intraepithelial neoplasia grade 1 with marked koilocytotic atypia

被引:9
|
作者
Ziol, M [1 ]
Di Tomaso, C
Biaggi, A
Tepper, M
Piquet, P
Carbillon, L
Uzan, M
Guettier, C
机构
[1] Hop Jean Verdier, Serv Anat Pathol, Dept Pathol, F-93143 Bondy, France
[2] Hop Jean Verdier, Dept Gynecol, F-93143 Bondy, France
[3] Univ Paris 13, Grp Immunopathol, Bobigny, France
关键词
cervical intraepithelial neoplasia; human papillomavirus; in situ hybridization; cervical biopsy;
D O I
10.1016/S0046-8177(98)90415-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of this study was to evaluate virologic and biological significance of marked koilocytotic atypia observed in some cases of grade I cervical intraepithelial neoplasia (CIN I). Thirty-one CIN I cervical biopsy specimens with marked koilocytotic atypia, defined by the presence of meganuclei in the superficial epithelial layers, were compared to 37 CIN I biopsy specimens with usual koilocytes for (1) the human papillomavirus (HPV) type and signal pattern as detected by nonisotopic in situ hybridization (ISH); (2) the proliferation index assessed by Ki 67 immunostaining and (3) the p53 labeling pattern. Interobserver agreement for meganuclei was excellent (k = 0.9). Twenty-five out of 68 biopsies (37%) were positive by ISH for the 6 of 11 HPV probe, 30 (44%) for the 16-18 probe, and 7 (10%) for the 31/33 HPV probe, 6 (9%) were negative for ISH. The presence of meganuclei was strongly related to high and intermediate risk HPV type (P = 0.0001). The sensitivity and specificity of meganuclei for the detection of high or intermediate risk HPV in CINI were 73 and 87%, respectively. Loss of p53 immunostaining in the lower third of the epithelium was also related to the presence of meganuclei (P < .05), but the MIB-1 index and ISH labeling pattern were not. In conclusion, marked koilocytotic atypia in CIN I is a reliable and sensitive marker for infection by high or intermediate-risk HPV, and might be a guide to therapy. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:1068 / 1073
页数:6
相关论文
共 50 条
  • [1] The significance of marked nuclear atypia in grade 1 cervical intraepithelial neoplasia
    Fadare, Oluwole
    Rodriguez, Rosemarie
    HUMAN PATHOLOGY, 2009, 40 (10) : 1487 - 1493
  • [2] The Significance of Marked Nuclear Atypia in Grade 1 Cervical Intraepithelial Neoplasia
    Fadare, Oluwole
    Rodriguez, Rosemarie
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (04) : 629 - 630
  • [3] Does Basal Atypia in Early Cervical Intraepithelial Neoplasia Belong to High Grade Squamous Intraepithelial Lesion?
    Lee, Y.
    Park, S.
    Choi, J.
    Lee, J. J.
    Kim, K-R
    LABORATORY INVESTIGATION, 2009, 89 : 224A - 224A
  • [4] Does Basal Atypia in Early Cervical Intraepithelial Neoplasia Belong to High Grade Squamous Intraepithelial Lesion?
    Lee, Y.
    Park, S.
    Choi, J.
    Lee, J. J.
    Kim, K-R
    MODERN PATHOLOGY, 2009, 22 : 224A - 224A
  • [5] CERVICAL INTRAEPITHELIAL NEOPLASIA AND KOILOCYTOTIC LESIONS OF THE LOWER GENITALIA IN AN ICELANDIC POPULATION
    SIGURDSSON, K
    BENEDIKTSDOTTIR, K
    SNORRADOTTIR, M
    SAEMUNDSSON, H
    OLAFSSON, JH
    EINARSSON, GV
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (02) : 49 - 57
  • [7] Cervical intraepithelial neoplasia grade 3
    Soergel, P.
    Jentschke, M.
    Hillemanns, P.
    GYNAKOLOGE, 2012, 45 (04): : 276 - 280
  • [8] Efficiency of the pharmacological treatment for the grade 1 cervical intraepithelial neoplasia
    Andzane, Diana
    Zodzika, Jana
    Jermakova, Irina
    Senefelde, Ilva
    Utorova, Marina
    Rezeberga, Dace
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 45 - 45
  • [9] The Clinical Meaning of a Cervical Intraepithelial Neoplasia Grade 1 Biopsy
    Castle, Philip E.
    Gage, Julia C.
    Wheeler, Cosette M.
    Schiffman, Mark
    OBSTETRICS AND GYNECOLOGY, 2011, 118 (06): : 1222 - 1229
  • [10] Biological behaviour of cervical intraepithelial neoplasia
    Syrjanen, KJ
    NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, 1997, : 93 - 108